"DEC PHARMA IS A FAST-GROWING COMPANY SERVICING THE PHARMACEUTICAL SECTOR BY OFFERING FLEXIBLE CRO AND CONSULTING SERVICES, A RANGE OF TECHNOLOGY FOR OUT-LICENSING AND TECHNICAL TRANSFER, AND VERSATILE GLOBAL SOURCING SOLUTIONS". DEC Pharma provides end-to-end discovery and development services. Our Multidisciplinary capabilities and Integrated Product Development strategy allow for a range of Consulting and CRO services for the Pharmaceutical sector, and comprehensive API and FDF Technologies targeting the Chinese Markets. Comprehensive formulation and retro-formulation programs are offered, together with Pre-Biostudy/Pilot Bio-Study packages to maximize pivotal Bio-Study and the registration procedures.

Our professional team is accomplished both in international business and the products of medicines and chemicals, our clients are mainly located in Europe, America, Middle East and Africa. We can not only do the general import and export business, but also can assist clients from market analysis to products registration, products design and contract manufacturing. Our specialized services and cordially working style, which are appreciated by our clients, made our business increased rapidly. We will keep on providing satisfying services to our existing clients,and in the same time, welcome more clients to cooperate with us to make the further development mutualy.

LIBANG has enhanced itself by providing fine APIs with well-accepted quality standard, intensive experiences in development and production, documentation for registration purposes, and excellent support for technical questions. LIBANG has specialized in developing generic Active Pharmaceutical Ingredients and related intermediates for customers´ requirements. Scale-up Plant occupies 10000 square meters, with workshop area of 400 square meters and clean room area of 240 square meters. The plant has been successfully audited by US FDA 3 times and SFDA 3 times since 1999. In the end of 2002, the plant is rebuilt based on the guideline of International recognized cGMP standards that comprises of 4 synthesis workshops, 9 production workshops, 3 clean workshops and 1 QC lab. The scale-up plant can handle reactions from 1 to 1000 kg scale. The plant is able to handle solid and liquid products, operate the multi tons reactions with a temperature range from -50°C to +200°C, and handle high-pr

Ling international Pharmaceutical Co., Ltd. Headquarters in shijiazhuang. Founded in 1992, it now has more than 3,000 employees and went public in 2011. Its sales team of more than 2,000 people, covering large and medium hospitals. Annual sales reached 3 billion yuan. Yiling international pharmaceutical has 3 oral solid preparation workshops. The conventional preparation workshop is located in shijiazhuang, with an annual production capacity of 3 billion tablets. Another sex hormone workshop, and highly active preparation workshop located in Beijing miyun, annual capacity of 200 million tablets. Yiling international pharmaceutical factory has passed GMP certification of New Zealand, UK, Australia and Canada, and its products are exported to all countries in the world.

Our company is located in Shangyu fine chemical industry park. We are a new manufacturer of raw material medicine and formulation drug. Focusing on high-quality production of drugs, the factory will become a CFDA, cGMP, US FDA, CEP, EU GMP, TGA, PMDA, Anvisa, cofepris and other certified factory.            Closely focus on the background requirements of "stability": high safety in production, high cleanness in emission, high quality, high standard in system, and the whole production chain of the industry, so as to ensure stable production, stable quality, stable price, stable supply capacity and stable GMP system.

Founded in September 2003, with a registered capital of 300 million yuan, it focuses on the production and processing of pharmaceutical formula granules, Chinese herbal medicine pieces, Chinese patent medicine preparations, plant extracts (feed supplements, mushroom polysaccharides, OEM), and daily chemical products. A comprehensive pharmaceutical enterprise integrating development, domestic and foreign trade sales, with a factory building and production workshop that meets GMP requirements, and dozens of high-end testing instruments for product testing and quality control. There are 4 production lines of Chinese medicine decoction pieces and Chinese medicine formula granules, plant extracts and oral solid preparations. Determined to become a warehouse, R & D and production base of medicinal materials, decoction pieces and formula granules in Zhejiang Province.

 Zhejiang Ruixin Pharmaceutical Co.,Ltd. is a comprehensive pharmaceutical company specializing  in producing a variety of dosage forms,bulk drug and fermentation extraction drug. The company’s predecessor was founded in 1966, named Zhenan Pharmaceutical Co.,Ltd. Which was reorganized as “Zhejiang Ruixin pharmaceutical Co.,Ltd.”in 2002. The factory covers an area of 33,300m2, led by general manager, is constructed with quality control, quality assurance and quality inspection as the center of three major quality assurance systems, and corresponding production management system, sales system and financial logistics management system to ensure the quality of products.

Located in Zhuhai, the Foreign Trade Featured Biomedical Industrial Cluster (“the Industrial Cluster”) is the only one of its kind in Mainland China connecting to Hong Kong and Macao by land. During the past 20 years, it has developed into a biomedical industrial cluster covering an area of 13 square kilometers and having approx. 16,000 employees by virtue of the favorable policies and industrial supporting advantages. As the home to over 1,000 biomedical enterprises, the Industrial Cluster has achieved the gross industrial output value of over RMB 100 billion, ranking top 3 Biomedical Industrial Clusters in Guangdong Province. It is reputed as Drug Valley in South China. So far, the Industrial Cluster has six public service and innovation platforms, a national key laboratory, twenty-four enterprise technology centers and engineering centers at national, provincial or municipal level, two university affiliated biomedical public laboratories, and seven post-doctoral scientific research stations. The industrial public service system has been completed.     Regionally based in Jinwan District, the Industrial Cluster promotes vigorously the development of High-tech Zone Foreign Trade Featured Medical Apparatus Industrial Cluster, Hengqin New Area Medicine Circulation and Foreign Trade Featured Guangdong-HK-Macao TCM Cooperation Industrial Cluster. An industrial layout has been well established, integrating biological medicines, chemical medicines, medical apparatuses, and health care products. The Industrial Cluster has become an integral part of global biomedical industrial chain.